Final Call for submissions: Ethical, Legal, and Social Implications (ELSI) of genomic research
Published in Social Sciences, Genetics & Genomics, and Public Health
What is this collection about?
This Collection focuses on the ethical, legal, and social implications of genomic research as the field rapidly evolves. It explores issues such as data governance, consent, access, equity, emerging technologies, and policy implications for public health and medical care. Submissions close on 04 June 2026.
Why is this collection important?
Genomic research is increasingly shaping clinical care, public health programmes, and society at large. While its potential benefits are significant, new technologies and data practices raise complex questions about fairness, trust, accountability, and long‑term impact. Addressing these challenges is essential if genomics is to improve health outcomes responsibly and equitably.
This Collection is timely because it brings ethical, legal, and social perspectives into direct conversation with scientific and policy innovation. It offers a dedicated forum for research that can inform governance, guide best practice, and shape public dialogue around genomic technologies. Researchers should submit to this Collection to ensure their work reaches a multidisciplinary audience engaged with both the opportunities and the responsibilities of genomic research, and to contribute to evidence that can influence policy, practice, and future research directions.
This Collection also supports research aligned with United Nations Sustainable Development Goal 3: Good Health and Well‑being, by promoting responsible, inclusive approaches to genomic science.
Why submit to a collection?
Collections like this one help promote high‑quality science. They are led by Guest Editors and In‑House Editors who are experts in their fields and supported by a dedicated team of Commissioning Editors and Managing Editors at Springer Nature. Collection manuscripts typically see higher citations, downloads, and Altmetric scores, and provide a one‑stop shop on a cutting‑edge topic of interest.
Who is involved?
- Nanibaa' Garrison, PhD, University of California, USA
- Bartha Maria Knoppers, PhD, AdE, OC, OQ, FRSC, FCAHS McGill University, Canada
- Eric Meslin, PhD, FRSC, FCAHS, ICDD University of Toronto, Canada
How can I submit my paper?
Visit the Collection page to find out more about this collection and submit your article.
Follow the Topic
-
BMC Medical Genomics
An open access journal publishing original peer-reviewed research articles in all aspects of functional genetics and genomics, genome structure, genome-scale population genetics, epigenetics and epigenomics, proteomics, systems analysis, and pharmacogenomics in relation to human health and disease.
Related Collections
With Collections, you can get published faster and increase your visibility.
Genomic drivers of non-communicable disease
BMC Medical Genomics is calling for submissions to our Collection on Genomic drivers of non-communicable disease. Non-communicable diseases (NCDs) such as cardiovascular diseases, diabetes, and neurogenerative diseases are major contributors to global morbidity and mortality, with complex interactions between genetic, environmental, and lifestyle factors. Understanding the genomic drivers of these chronic diseases is crucial for unraveling their etiology and developing effective prevention and treatment strategies.
Recent advances in genomic technologies, such as next-generation sequencing and genome-wide association studies, have revolutionized our understanding of the genetic architecture of NCDs. These innovations have enabled researchers to identify novel biomarkers and therapeutic targets, paving the way for personalized interventions. As we continue to explore the genetic basis of these diseases, we can develop more effective strategies for prevention, early detection, and tailored treatment approaches.
Continued research in this field has the potential to unveil novel genomic targets and pathways that could lead to innovative therapeutic strategies. As our understanding deepens, we may see the emergence of personalized medicine approaches that not only improve patient outcomes but also reduce the burden of non-communicable diseases on healthcare systems globally. Potential topics include but are not limited to:
- Role of SNPs in non-communicable diseases
- Gene expression patterns in chronic diseases
- Genomic markers for disease susceptibility
- Interactions between genetics and lifestyle factors
This collection supports and amplifies research related to SDG #3: Good Health and Well-Being
All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer-review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.
Publishing Model: Open Access
Deadline: Apr 30, 2027
Genomic equity: screening strategies for underserved populations
BMC Medical Genomics invites submissions for a Collection on Genomic equity: screening strategies for underserved populations.
The rapid advancements in genomic technologies present an unprecedented opportunity to improve health outcomes through targeted genetic screening. However, these benefits are not uniformly accessible, particularly among underserved populations who often face systemic barriers to healthcare. This Collection focuses on understanding and addressing the disparities in genomic screening strategies for marginalized communities. We invite researchers to contribute their insights on the development and implementation of equitable screening practices that consider the unique genetic and environmental contexts of these populations.
Addressing genomic equity is vital for ensuring that all individuals benefit from advancements in medical genomics. Recent strides have been made in public health genomics to identify and rectify health disparities, emphasizing the importance of inclusive practices in genetic screening. By leveraging community engagement and culturally competent healthcare delivery, researchers are beginning to uncover effective methods to reach underserved populations. These approaches are essential to fostering health equity and ensuring that genomic innovations translate into real-world benefits for all.
As research in this field continues to evolve, we may see transformative advancements that enhance the accessibility and effectiveness of genetic screening for underserved populations. Future studies could lead to the establishment of comprehensive frameworks for integrating genomic data into routine healthcare practices, thereby facilitating personalized medicine for those who need it most. The potential for community-driven initiatives to shape genomic health policies is promising, paving the way for a more equitable future in healthcare.
The Collection welcomes original research articles on topics including but not limited to:
- Strategies for equitable genetic screening
- Addressing health equity in genomic research
- Public health genomics and marginalized communities
This Collection supports and amplifies research related to SDG 3 (Good Health and Well-being).
All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.
Publishing Model: Open Access
Deadline: Feb 13, 2027
Please sign in or register for FREE
If you are a registered user on Research Communities by Springer Nature, please sign in